Evidence map›Paper›PMID 26387735›Full record

ArticleMolecular cell2015

SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore.

Santhanam Shanmughapriya, Sudarsan Rajan, Nicholas E Hoffman, Andrew M Higgins, Dhanendra Tomar, Neeharika Nemani, Kevin J Hines, Dylan J Smith, Akito Eguchi, Sandhya Vallem and 12 more

Abstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 3 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 3 syntheses or guidelines pooled it, 198 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. CypD Dependent mPTP Opening Is Crucial for Oxidized Mitochondrial DNA Release in Ferroptosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Phenotypic CRISPR screens identify NLRX1 as an essential activator of the human mitochondrial permeability transition.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. 3-Methyl Glutaconic Aciduria and Elevated Plasma Growth Differentiation Factor 15 Level in an Adult with MonoallelicActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2025
    Article
  13. PPIFJournal of translational medicine · 2025
    Article
  14. Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson's Disease.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Santhanam ShanmughapriyaDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Sudarsan RajanDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Nicholas E HoffmanDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Andrew M HigginsDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Dhanendra TomarDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Neeharika NemaniDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Kevin J HinesDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Dylan J SmithDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Akito EguchiDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Sandhya VallemDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Farah ShaikhDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Maggie CheungDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Nicole J LeonardDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Ryan S StolakisDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Matthew P WolfersDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Jessica IbettiCenter for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
J Kurt ChuprunCenter for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Neelakshi R JogDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Steven R HouserCardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Walter J KochCenter for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
John W ElrodCenter for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Muniswamy MadeshDepartment of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA. Electronic address: madeshm@temple.edu.
Temple University · US

Funding

Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury RepairP01HL091799 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KOCH, WALTER J. · 2008 to 2018
$23.1M
Project 3 Dysregulation of metabolic communication of oligodendrocytes and neurons by cocaine and TatP01DA037830 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI KHALILI, KAMEL · 2015 to 2019
$7.4M
Coordination of Pathophysiologic Endothelial Cell Signaling by ROSR01HL086699 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2008 to 2018
$4.3M
Spectral revelations of mitochondrial Ca2+ flux interactomeR01GM109882 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2014 to 2022
$3.3M
Mechanisms of mitochondrial calcium exchange in heart failureR01HL123966 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI ELROD, JOHN WILLIAM · 2014 to 2018
$2.3M
Inhibition of MCUR1-MCU mediated mitochondrial Ca2+ uptake prevents I/R injuryR01HL119306 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI MUNISWAMY, MADESH · 2014 to 2017
$1.6M
Multiphoton Confocal Microscopy for Biomedical ResearchS10RR027327 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · PI MUNISWAMY, MADESH · 2010 to 2010
$500k
NCRR NIH HHS 1S10RR027327NCRR NIH HHS S10 RR027327NHLBI NIH HHS P01 HL091799NHLBI NIH HHS R01 HL086699NHLBI NIH HHS R01HL086699NHLBI NIH HHS R01 HL119306NHLBI NIH HHS R01HL119306NHLBI NIH HHS R01 HL123966NIDA NIH HHS P01 DA037830NIGMS NIH HHS R01 GM109882NIGMS NIH HHS R01GM109882
6 · The paper itself

Abstract

Mitochondrial permeability transition is a phenomenon in which the mitochondrial permeability transition pore (PTP) abruptly opens, resulting in mitochondrial membrane potential (ΔΨm) dissipation, loss of ATP production, and cell death. Several genetic candidates have been proposed to form the PTP complex, however, the core component is unknown. We identified a necessary and conserved role for spastic paraplegia 7 (SPG7) in Ca(2+)- and ROS-induced PTP opening using RNAi-based screening. Loss of SPG7 resulted in higher mitochondrial Ca(2+) retention, similar to cyclophilin D (CypD, PPIF) knockdown with sustained ΔΨm during both Ca(2+) and ROS stress. Biochemical analyses revealed that the PTP is a heterooligomeric complex composed of VDAC, SPG7, and CypD. Silencing or disruption of SPG7-CypD binding prevented Ca(2+)- and ROS-induced ΔΨm depolarization and cell death. This study identifies an ubiquitously expressed IMM integral protein, SPG7, as a core component of the PTP at the OMM and IMM contact site.

Indexed as

ATPases Associated with Diverse Cellular ActivitiesBinding SitesCalciumCell DeathCyclophilinsHEK293 CellsHeLa CellsHumansMembrane Potential, MitochondrialMetalloendopeptidasesMitochondriaMitochondrial MembranesPeptidyl-Prolyl Isomerase DReactive Oxygen SpeciesRNA InterferenceVoltage-Dependent Anion Channel 1ATPases Associated with Diverse Cellular ActivitiesCalciumCyclophilinsMetalloendopeptidasesPeptidyl-Prolyl Isomerase DPPID protein, humanReactive Oxygen SpeciesSPG7 protein, humanVDAC1 protein, humanVoltage-Dependent Anion Channel 1

Identifiers

PMID26387735
PMCPMC4592475
OpenAlexW1895235630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.